Quarterly
Annual
| Unit: USD | 2024-03-30 |
|---|---|
operating activities: | |
net income | -347,902,000 |
adjustments to reconcile net income to cash from operating activities: | |
depreciation and amortization | 10,403,000 |
amortization of deferred financing costs and debt discount | 1,254,000 |
impairment of franchise rights acquired | 257,988,000 |
impairment of intangible and long-lived assets | 24,000 |
share-based compensation expense | 2,402,000 |
deferred tax benefit | -18,244,000 |
allowance for doubtful accounts | 2,757,000 |
reserve for inventory obsolescence | 85,000 |
foreign currency exchange rate gain | -1,304,000 |
changes in cash due to: | |
receivables | 3,788,000 |
inventories | 79,000 |
prepaid expenses | 13,882,000 |
accounts payable | 4,130,000 |
accrued liabilities | -26,393,000 |
deferred revenue | 2,321,000 |
other long term assets and liabilities | -1,796,000 |
income taxes | 60,491,000 |
cash from operating activities | -36,035,000 |
investing activities: | |
capital expenditures | -476,000 |
free cash flows | -36,511,000 |
capitalized software and website development expenditures | -4,333,000 |
other items | -1,000 |
cash from investing activities | -4,810,000 |
financing activities: | |
taxes paid related to net share settlement of equity awards | -114,000 |
proceeds from stock options exercised | |
cash paid for acquisitions | -500,000 |
cash from financing activities | -616,000 |
effect of exchange rate changes on cash and cash equivalents | -1,290,000 |
net decrease in cash and cash equivalents | -42,751,000 |
cash and cash equivalents, beginning of period | 109,366,000 |
cash and cash equivalents, end of period | 66,615,000 |
The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
